+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Clinical Nutrition For Chronic Kidney Diseases Market Size, Share & Trends Analysis Report by Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 5976494
Description Jump to:
The global clinical nutrition for chronic kidney diseases market size is estimated to reach USD 2.37 billion by 2030, growing at a CAGR of 6.03% during the forecast period. chronic kidney diseases (CKDs) present a substantial challenge, notably in low- and middle-income countries that lack adequate resources for effective management. Globally, CKD has emerged as a significant cause of death and is one of the rare non-communicable diseases experiencing an increase in mortality rates over the past two decades.

The rising global incidence of CKDs has led to the creation of a diverse array of nutritional supplements designed to address the specific dietary needs of CKD patients. This trend emphasizes the significance of continuous research and innovation in developing efficient and secure supplements that promote kidney health and overall well-being for individuals suffering from CKD.

The increasing awareness among the people and healthcare professionals to treat such deficiencies has resulted in the rising demand for oral clinical nutrition products. Research in natural compounds and nutraceuticals has expanded the scope for market growth. Some prominent examples include nutraceuticals comprising polyunsaturated fatty acids, phytosterols, and phenolic compounds. Moreover, plant-derived compounds such as resveratrol and curcumin have been proven effective in reducing oxidative stress, thus slowing CKD progression and the consequent cardiovascular threats.

Technological advancements in allied industries, such as enteral feeding devices, positively impact market growth. Key players are launching products that can be administered through the enteral route, propelling the market growth. Furthermore, government support in the form of approvals is anticipated to fuel the market growth over the forecast period.

Clinical Nutrition For Chronic Kidney Diseases Market Report Highlights

  • Unhealthy lifestyles have led to the increasing burden of health issues such as lack of nutrition, obesity, poor immunity leading to the rise of chronic, neurological and autoimmune diseases.
  • Mergers, collaborations, partnerships, and product expansions characterize the market and propel market growth.
  • Oral nutrition dominated the product segment with a share of over 50% in 2023; however, parenteral formulas are anticipated to register lucrative growth in the future.
  • Adults led the stage segment with a revenue share of 85%. Individuals in the adult age group are increasingly experiencing decreased muscle strength, vitamin and calcium deficiencies, particularly among women over 30 years old, which has led to the segment growth.
  • Advancements in telemedicine have enabled the global distribution of clinical nutrition products, allowing manufacturers to broaden their market reach and cater to underserved communities. Thus, online sales are expected to aid market growth greatly over the forecast period.
  • Asia Pacific is anticipated to register the fastest CAGR of nearly 7% over the forecast period, owing to the increasing manufacturing facilities in the region and increased per capita healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Stage
1.2.3. Sales Channel
1.2.4. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Approach 1: Commodity Flow Approach
1.7.3. Volume Price Analysis (Model 2)
1.7.4. Approach 2: Volume Price Analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Stage Outlook
2.2.3. Sales Channels Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Clinical Nutrition for Chronic Kidney Diseases Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Estimates & Trend Analysis
4.1. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Dashboard
4.2. Global Clinical Nutrition for Chronic Kidney Diseases Market: Product Movement Analysis
4.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4. Oral Nutrition
4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Parenteral Nutrition
4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6. Enteral Feeding Formulas
4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Estimates & Trend Analysis
5.1. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Dashboard
5.2. Clinical Nutrition for Chronic Kidney Diseases Market: Stage Movement Analysis
5.3. Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4. Adult
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Pediatric
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Estimates & Trend Analysis
6.1. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Dashboard
6.2. Global Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Movement Analysis
6.3. Global Clinical Nutrition for Chronic Kidney Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4. Online
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Retail
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Institutional Sales
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Global Clinical Nutrition for Chronic Kidney Diseases Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key Country Dynamics
7.5.1.2. Regulatory Framework/Reimbursement Structure
7.5.1.3. Competitive Scenario
7.5.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework/Reimbursement Structure
7.5.2.3. Competitive Scenario
7.5.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key Country Dynamics
7.6.1.2. Regulatory Framework/Reimbursement Structure
7.6.1.3. Competitive Scenario
7.6.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework/Reimbursement Structure
7.6.2.3. Competitive Scenario
7.6.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework/Reimbursement Structure
7.6.3.3. Competitive Scenario
7.6.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework/Reimbursement Structure
7.6.4.3. Competitive Scenario
7.6.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework/Reimbursement Structure
7.6.5.3. Competitive Scenario
7.6.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.6. Denmark
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework/Reimbursement Structure
7.6.6.3. Competitive Scenario
7.6.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key Country Dynamics
7.6.7.2. Regulatory Framework/Reimbursement Structure
7.6.7.3. Competitive Scenario
7.6.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.8. Norway
7.6.8.1. Key Country Dynamics
7.6.8.2. Regulatory Framework/Reimbursement Structure
7.6.8.3. Competitive Scenario
7.6.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7. Asia-Pacific
7.7.1. China
7.7.1.1. Key Country Dynamics
7.7.1.2. Regulatory Framework/Reimbursement Structure
7.7.1.3. Competitive Scenario
7.7.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Japan
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework/Reimbursement Structure
7.7.2.3. Competitive Scenario
7.7.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework/Reimbursement Structure
7.7.3.3. Competitive Scenario
7.7.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key Country Dynamics
7.7.4.2. Regulatory Framework/Reimbursement Structure
7.7.4.3. Competitive Scenario
7.7.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.5. Thailand
7.7.5.1. Key Country Dynamics
7.7.5.2. Regulatory Framework/Reimbursement Structure
7.7.5.3. Competitive Scenario
7.7.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.6. South Korea
7.7.6.1. Key Country Dynamics
7.7.6.2. Regulatory Framework/Reimbursement Structure
7.7.6.3. Competitive Scenario
7.7.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key Country Dynamics
7.8.1.2. Regulatory Framework/Reimbursement Structure
7.8.1.3. Competitive Scenario
7.8.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework/Reimbursement Structure
7.8.2.3. Competitive Scenario
7.8.2.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework/Reimbursement Structure
7.8.3.3. Competitive Scenario
7.8.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key Country Dynamics
7.9.1.2. Regulatory Framework/Reimbursement Structure
7.9.1.3. Competitive Scenario
7.9.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key Country Dynamics
7.9.2.2. Regulatory Framework/Reimbursement Structure
7.9.2.3. Competitive Scenario
7.9.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key Country Dynamics
7.9.3.2. Regulatory Framework/Reimbursement Structure
7.9.3.3. Competitive Scenario
7.9.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key Country Dynamics
7.9.4.2. Regulatory Framework/Reimbursement Structure
7.9.4.3. Competitive Scenario
7.9.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of Key Distributors and Channel Partners
8.3.2. Key Customers
8.3.3. Key Company Market Share Analysis, 2023
8.3.4. Abbott Nutrition
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Bayer AG
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Nestle Health Science S.A.
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. GlaxoSmithKline Plc
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Baxter International Inc.
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Otsuka Holdings Co., Ltd.
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Mead Johnson & Company, LLC
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Danone Nutricia
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Victus, Inc.
8.3.13.1. Company Overview
8.3.13.2. Financial Performance
8.3.13.3. Product Benchmarking
8.3.13.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 Global Clinical Nutrition for Chronic Kidney Diseases Market, 2018-2030 (USD Million)
Table 3 Global Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 4 Global Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 5 Global Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 6 North America Clinical Nutrition for Chronic Kidney Diseases Market, by Country, 2018-2030 (USD Million)
Table 7 North America Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 8 North America Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 9 North America Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 10 U.S. Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 11 U.S. Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 12 U.S. Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 13 Canada Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 14 Canada Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 15 Canada Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 16 Europe Clinical Nutrition for Chronic Kidney Diseases Market, by Country, 2018-2030 (USD Million)
Table 17 Europe Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 18 Europe Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 19 Europe Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 20 UK Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 21 UK Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 22 UK Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 23 Germany Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 24 Germany Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 25 Germany Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 26 France Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 27 France Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 28 France Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 29 Italy Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 30 Italy Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 31 Italy Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 32 Spain Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 33 Spain Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 34 Spain Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 35 Denmark Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 36 Denmark Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 37 Denmark Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 38 Sweden Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 39 Sweden Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 40 Sweden Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 41 Norway Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 42 Norway Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 43 Norway Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 44 Asia-Pacific Clinical Nutrition for Chronic Kidney Diseases Market, by Country, 2018-2030 (USD Million)
Table 45 Asia-Pacific Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 46 Asia-Pacific Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 47 Asia-Pacific Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 48 China Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 49 China Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 50 China Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 51 Japan Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 52 Japan Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 53 Japan Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 54 India Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 55 India Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 56 India Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 57 Australia Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 58 Australia Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 59 Australia Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 60 Thailand Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 61 Thailand Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 62 Thailand Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 63 South Korea Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 64 South Korea Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 65 South Korea Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 66 Latin America Clinical Nutrition for Chronic Kidney Diseases Market, by Country, 2018-2030 (USD Million)
Table 67 Latin America Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 68 Latin America Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 69 Latin America Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 70 Brazil Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 71 Brazil Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 72 Brazil Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 73 Mexico Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 74 Mexico Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 75 Mexico Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 76 Argentina Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 77 Argentina Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 78 Argentina Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 79 MEA Clinical Nutrition for Chronic Kidney Diseases Market, by Country, 2018-2030 (USD Million)
Table 80 MEA Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 81 MEA Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 82 MEA Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 83 South Africa Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 84 South Africa Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 85 South Africa Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 86 Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 87 Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 88 Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 89 UAE Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 90 UAE Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 91 UAE Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
Table 92 Kuwait Clinical Nutrition for Chronic Kidney Diseases Market, by Product, 2018-2030 (USD Million)
Table 93 Kuwait Clinical Nutrition for Chronic Kidney Diseases Market, by Stage, 2018-2030 (USD Million)
Table 94 Kuwait Clinical Nutrition for Chronic Kidney Diseases Market, by Sales Channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Clinical Nutrition for Chronic Kidney Diseases Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Value Chain Based Sizing & Forecasting
Figure 6 QFD Modelling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot
Figure 9 Competitive Landscape Snapshot
Figure 10 Product and Stage Segment Snapshot
Figure 11 Sales Channel Segment Snapshot
Figure 12 Market Dynamics
Figure 13 Porter’s Five Forces Analysis
Figure 14 PESTLE Analysis
Figure 15 Clinical Nutrition for Chronic Kidney Diseases Market: Product Outlook and Key Takeaways
Figure 16 Clinical Nutrition for Chronic Kidney Diseases Market: Product Movement Analysis
Figure 17 Oral Nutrition Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 18 Parenteral Nutrition Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 19 Enteral Feeding Formulas Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 20 Clinical Nutrition for Chronic Kidney Diseases Market: Stage Outlook and Key Takeaways
Figure 21 Clinical Nutrition for Chronic Kidney Diseases Market: Stage Movement Analysis
Figure 22 Adult Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 23 Pediatric Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 24 Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Outlook and Key Takeaways
Figure 25 Clinical Nutrition for Chronic Kidney Diseases Market: Sales Channel Movement Analysis
Figure 26 Online Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 27 Retail Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 28 Institutional Sales Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 29 Clinical Nutrition for Chronic Kidney Diseases Market Revenue, by Region, 2023 & 2030 (USD Million)
Figure 30 Regional Marketplace: Key Takeaways (1/2)
Figure 31 Regional Marketplace: Key Takeaways (2/2)
Figure 32 North America Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Key Country Dynamics
Figure 34 U.S. Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Key Country Dynamics
Figure 36 Canada Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Key Country Dynamics
Figure 38 Europe Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Key Country Dynamics
Figure 40 UK Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Key Country Dynamics
Figure 42 Germany Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Key Country Dynamics
Figure 44 France Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Key Country Dynamics
Figure 46 Italy Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Key Country Dynamics
Figure 48 Spain Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Key Country Dynamics
Figure 50 Denmark Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Key Country Dynamics
Figure 52 Sweden Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Key Country Dynamics
Figure 54 Norway Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key Country Dynamics
Figure 56 Asia-Pacific Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key Country Dynamics
Figure 58 China Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Key Country Dynamics
Figure 60 Japan Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Key Country Dynamics
Figure 62 India Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Key Country Dynamics
Figure 64 Australia Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Key Country Dynamics
Figure 66 Thailand Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Key Country Dynamics
Figure 68 South Korea Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Key Country Dynamics
Figure 70 Latin America Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 71 Key Country Dynamics
Figure 72 Brazil Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 73 Key Country Dynamics
Figure 74 Mexico Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 75 Key Country Dynamics
Figure 76 Argentina Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 77 Key Country Dynamics
Figure 78 MEA Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 79 Key Country Dynamics
Figure 80 South Africa Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 Key Country Dynamics
Figure 82 Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 83 Key Country Dynamics
Figure 84 UAE Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 85 Key Country Dynamics
Figure 86 Kuwait Clinical Nutrition for Chronic Kidney Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 87 Key Country Dynamics
Figure 88 Company Market Share Analysis, 2023
Figure 89 Strategic Framework

Companies Mentioned

  • Abbott Nutrition
  • Pfizer Inc.
  • Bayer AG
  • Nestle Health Science S.A.
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings Co., Ltd.
  • Mead Johnson & Company, LLC
  • Danone Nutricia
  • Victus, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.37 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Chronic Kidney Disease Market by Type (Diagnosis, Treatment), Indication (Chronic Interstitial Nephritis, Diabetic Nephropathy, Glomerulonephritis), End-User - Forecast 2024-2030 - Product Image

Global Chronic Kidney Disease Market by Type (Diagnosis, Treatment), Indication (Chronic Interstitial Nephritis, Diabetic Nephropathy, Glomerulonephritis), End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Kidney Disease Global Market Report 2024 - Product Image

Kidney Disease Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Diabetic Kidney Disease Global Market Report 2024 - Product Image

Diabetic Kidney Disease Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Global Polycystic Kidney Disease Market - Product Image

Global Polycystic Kidney Disease Market

  • Report
  • 200 Pages
  • Global
From

About the Clinical Nutrition For Chronic Kidney Diseases Market

In the field of urology and nephrology, clinical nutrition for chronic kidney diseases (CKD) constitutes an essential aspect of patient care. CKD is characterized by the gradual loss of kidney function over time and can lead to end-stage renal disease (ESRD), necessitating dialysis or transplantation. Proper nutrition is critical for managing CKD, as it helps to slow disease progression, improve patient outcomes, and reduce the risk of complications. Dietary interventions typically focus on controlling intake of protein, phosphorus, potassium, sodium, and fluids to alleviate the burden on the kidneys and address electrolyte imbalances. Renal dietitians play a pivotal role in devising individualized nutrition plans based on the stages of CKD and the specific needs of each patient. Several companies specialize in the development and provision of nutritional products and services tailored for CKD patients. These firms often offer renal-specific supplements and meals designed to comply with the restricted dietary requirements associated with CKD management. Among the notable players in the market are Abbott Laboratories, Nestlé Health Science, Baxter Healthcare, Fresenius Kabi, and Nutricia. These companies not only supply nutritional products but also provide educational resources and support to healthcare professionals, patients, and caregivers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.